The development and application of a surface plasmon resonance-based inhibition immunoassay for the determination of warfarin in plasma ultrafiltrate

Journal of Immunological Methods

Volumn 291, Issue 1-2, 2004, Pages 11-25

  Fitzpatrick, Brian ^a   O'Kennedy, Richard ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

bovine serum albumin; BSA; carboxymethylated; CM; high performance liquid chromatography; HPLC; infrared; Inhibition immunoassay; IR; keyhole limpet haemocyanin; KLH; NMR; Nonprotein bound; Response units; RU; Surface plasmon resonance; Ultrafiltration; Warfarin

Indexed keywords

ACENOCOUMAROL; WARFARIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOASSAY; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SURFACE PLASMON RESONANCE; ULTRAFILTRATION;

ANIMALS; ANTIBODIES; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS; CALIBRATION; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXTRACELLULAR MATRIX PROTEINS; HEMOFILTRATION; HUMANS; IMMUNOASSAY; LIGANDS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN, BOVINE; SODIUM CHLORIDE; SUBSTRATE SPECIFICITY; SURFACE PLASMON RESONANCE; ULTRAFILTRATION; WARFARIN;

BOVINAE;

EID: 4444369935     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.03.015     Document Type: Article

References (27)

1. Amirkhosravi M., Francis J.L. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation. Thromb. Haemost. 73(1):1995;59
2. Bertucci C., Canepa A., Ascoli G.A., Guimaraes L.F.L., Felix G. Site I on human albumin: differences in the binding of (R)- and (S)-warfarin. Chirality. 11(9):1999;675
3. Boder E.T., Midelfort K.S., Wittrup K.D. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding site. Proc. Natl. Acad. Sci. U. S. A. 97(20):2000;10701
4. Brennan J., Dillon P., O'Kennedy R. The production, purification and characterisation of genetically-derived scFv and bifunctional antibody fragments capable of detecting illicit drug residues. J. Chromatogr., B, Biomed. Sci. Appl. 18:2003;217
5. Capitán-Vallvey L.F., Deheldel M.K.L., Avidad R. Determination of warfarin in waters and human plasma by solid phase room-temperature transmitted phosphorescence. Arch. Environ. Contam. Toxicol. 37:1999;1
6. Chapuzet E., Mercier N., Bervoas-Martin S., Boulanger B., Chevalier P., Chiap P., Grandjean D., Hubert P., Lagorce P., Lallier M., Laparra M.C., Laurentie M., Nivet J.C. Méthodes chromatographiques de dosage les milieus biologiques: stratégie de validation Rapport d'une commission SFSTP. STP Pharma Prat. 7(3):1997;169
7. Cooke D., Fitzpatrick B., O'Kennedy R., McCormack T., Egan D. O'Kennedy R., Thornes R.D. Coumarins: Biology, Applications and Mode of Action. 1997;303 Wiley, Chichester
8. Crooks S.R.H., Baxter G.A., O'Connor M., Elliot C.T. Immunobiosensor - an alternative to enzyme immunoassay screening for residues of two sulfonamides in pigs. Analyst. 123:1998;2755
9. 1. J. Agric. Food Chem. 48(11):2000;5097
10. Dockal M., Carter D.C., Ruker F. The three recombinant domains of human serum albumin. J. Biol. Chem. 274(41):1999;29303
11. Findlay J.W.A., Smith W.C., Lee J.W., Nordblom G.D., Das I., DeSilva B.S., Khan M.N., Bowsher R.R. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J. Pharm. Biomed. Anal. 21:2000;1249
12. Fitzpatrick, B., 2001. The production, characterisation and applications of polyclonal and monoclonal antibodies to warfarin. PhD thesis, Dublin City University, Dublin, Ireland.
13. Hirsh J., Dalen J.E., Deykin D., Poller L., Bussey H. Oral Anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 108(4):1995;231s
14. Ikawa M., Stahmann M.A., Link K.P. Studies on 4-hydroxycoumarins: V. The condensation of α, β-unsaturated ketones with 4-hydroxycoumarins. J. Am. Chem. Soc. 66:1944;902
15. Jönsson U., Fagerstam L., Ivarsson B., Lundh K., Löfas S., Persson B., Roos H., Rönnberg L., Sjölander S., Stenberg E., Stahlberg R., Urbaniczky C., Östlin H., Malmqvist M. Real-time biospecific interaction analysis using surface plasmon resonance and a sensorchip technology. BioTechniques. 11:1991;620
16. Jortani S.A., Pinar A., Johnson N.A., Valdes R. Validity of unbound digoxin measurement by immunoassays in presence of antidote (Digibind). Clin. Chim. Acta. 283:1999;159
17. King S.-H.P., Joslin M.A., Raudibaugh K., Pieniaszek H.J. Jr., Benedek I.H. Dose-dependent pharmacokinetics of warfarin in healthy volunteers. Pharm. Res. 12(12):1995;1874
18. Link K.P. The anticoagulant from spoiled sweet clover hay. Harvey Lect. Ser. 39:1943-1944;162
19. Menguy T., Chenevois S., Guillain F., le Maire M., Falson P., Champeil P. Ligand binding to macromolecules or micelles: use of centrifugal ultrafiltration to measure low-affinity binding. Anal. Biochem. 264(2):1998;141
20. Quinn J., Patel P., Fitzpatrick B., Manning B., Dillon P., Daly S., O'Kennedy R., Alcocer M., Lee H., Morgan M., Lang K. The use of regenerable, affinity ligand-based surfaces for immunosensor applications. Biosens. Bioelectron. 14:1999;587
21. Ring P.R., Bostick J.M. Validation of a method for the determination of (R)-warfarin and (S)-warfarin in human plasma using LC with UV detection. J. Pharm. Biomed. Anal. 22:2000;573
22. Satoh H., Hayashi M., Satoh S. Anti-warfarin antibody preparation and it's characterisation for radioimmunoassay. J. Pharm. Pharmacol. 34:1982;429
23. Thaisrivongs S., Strohbach J.W. Structure-based discovery of Tipranavir disodium (PNU-140690E): a potent, orally bioavailable, nonpeptidic HIV protease inhibitor. Biopolymers. 51(1):1999;51
24. Wells P.S., Holbrook A.M., Crowther N.R., Hirsh J. Interactions of warfarin with drugs and food. Ann. Intern. Med. 121(9):1994;676
25. Wong R.L., Mytych D., Jacobs S., Bordens R., Swanson S.J. Validation parameters for a novel biosensor assay which simultaneously measures serum concentrations of a humanized monoclonal antibody and detects induced antibodies. J. Immunol. Methods. 209:1997;1
26. Zacharski L.R., Henderson W.G., Rickles F.R., Forman W.B., Cornell C.J. Jr., Jackson Forcier R., Edwards R.L., Headley E., Kim S.-H., O'Donnell J.R., O'Dell R., Tornyos K., Kwaan H.C. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA co-operative study no. 75. Cancer. 53(10):1984;2046
27. Zilva J.F., Pannell P.R. Clinical Chemistry in Diagnosis and Treatment. third edition:1979;Lloyd-Duke, London, England